Mirtazapine, an antidepressant

Jan 23, 1998American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Mirtazapine, an antidepressant

AI simplified

Abstract

Mirtazapine is FDA-approved for treating depression and may also aid in anxiety management.

  • Mirtazapine blocks specific receptors involved in neurotransmission, which may enhance its antidepressant effects.
  • Patients taking mirtazapine demonstrated significantly greater improvement in depression symptoms compared to those on placebo, as measured by the Hamilton Rating Scale for Depression.
  • It has shown comparable efficacy to other established antidepressants such as amitriptyline, clomipramine, and doxepin.
  • Common adverse effects include somnolence, increased appetite, weight gain, and dizziness, but mirtazapine is generally well tolerated.
  • The recommended starting dosage is 15 mg/day, taken as a single dose at bedtime.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free